Biomedical Innovation Expansion Act of 2019

I 116TH CONGRESS 1ST SESSION H. R. 4667 To amend the 21st Century Cures Act to reauthorize funding for NIH innovation projects, and for other purposes. IN THE HOUSE OF REPRESENTATIVES OCTOBER 11, 2019 Ms. SHERRILL (for herself, Mr. LEVIN of California, and Ms. SPANBERGER) introduced the following bill; which was referred to the Committee on En- ergy and Commerce A BILL To amend the 21st Century Cures Act to reauthorize funding for NIH innovation projects, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Biomedical Innovation 4 Expansion Act of 2019’’. 5 SEC. 2. REAUTHORIZATION OF NIH INNOVATION PROJ- 6 ECTS. 7 (a) TRANSFERS.—Section 1001(b)(2)(A) of the 21st 8 Century Cures Act (Public Law 114–255) is amended by 9 VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS 2 •HR 4667 IH striking clauses (v) through (x) and inserting the fol- 1 lowing: 2 ‘‘(v) For fiscal year 2021, 3 $854,000,000. 4 ‘‘(vi) For fiscal year 2022, 5 $1,051,000,000. 6 ‘‘(vii) For fiscal year 2023, 7 $1,345,000,000. 8 ‘‘(viii) For fiscal year 2024, 9 $1,271,000,000. 10 ‘‘(ix) For fiscal year 2025, 11 $1,301,000,000. 12 ‘‘(x) For fiscal year 2026, 13 $1,306,000,000. 14 ‘‘(xi) For fiscal year 2027, 15 $1,336,000,000. 16 ‘‘(xii) For fiscal year 2028, 17 $1,376,000,000. 18 ‘‘(xiii) For fiscal year 2029, 19 $1,436,000,000. 20 ‘‘(xiv) For fiscal year 2030, 21 $1,469,000,000.’’. 22 (b) AUTHORIZATION OF APPROPRIATIONS.—Section 23 1001(b)(3)(A) of the 21st Century Cures Act (Public Law 24 VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS 3 •HR 4667 IH 114–255) is amended by striking ‘‘2026’’ and inserting 1 ‘‘2030’’. 2 (c) OFFSETTING FUTURE APPROPRIATIONS.—Sec- 3 tion 1001(b)(3)(B) of the 21st Century Cures Act (Public 4 Law 114–255) is amended by striking ‘‘2026’’ and insert- 5 ing ‘‘2030’’. 6 (d) NIH INNOVATION PROJECTS.—Section 7 1001(b)(4) of the 21st Century Cures Act (Public Law 8 114–255) is amended— 9 (1) in the matter preceding subparagraph (A), 10 by striking ‘‘2026’’ and inserting ‘‘2030’’; 11 (2) in subparagraph (A)— 12 (A) in the matter preceding clause (i), by 13 striking ‘‘$1,455,000,000’’ and inserting 14 ‘‘$4,413,000,000’’; and 15 (B) by striking clauses (v) through (x) and 16 inserting the following: 17 ‘‘(v) For fiscal year 2021, 18 $209,000,000. 19 ‘‘(vi) For fiscal year 2022, 20 $300,000,000. 21 ‘‘(vii) For fiscal year 2023, 22 $419,000,000. 23 ‘‘(viii) For each fiscal years 2024 24 through 2030, $430,000,000.’’; 25 VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS 4 •HR 4667 IH (3) in subparagraph (B)— 1 (A) in the matter preceding clause (i), by 2 striking ‘‘$1,511,000,000’’ and inserting 3 ‘‘$4,428,000,000’’; and 4 (B) by striking clauses (v) through (x) and 5 inserting the following: 6 ‘‘(v) For fiscal year 2021, 7 $250,000,000. 8 ‘‘(vi) For fiscal year 2022, 9 $302,000,000. 10 ‘‘(vii) For fiscal year 2023, 11 $450,000,000. 12 ‘‘(viii) For each of fiscal years 2024, 13 2025, and 2026, $400,000,000. 14 ‘‘(ix) For fiscal year 2027, 15 $425,000,000. 16 ‘‘(x) For fiscal years 2028, 17 $450,000,000. 18 ‘‘(xi) For each of fiscal years 2029 19 and 2030, $500,000,000.’’; 20 (4) in subparagraph (C)— 21 (A) in the matter preceding clause (i), by 22 striking ‘‘$1,800,000,000’’ and inserting 23 ‘‘$3,312,000,000’’; and 24 VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS 5 •HR 4667 IH (B) by amending clause (vii) to read as fol- 1 lows: 2 ‘‘(vii) For each of fiscal years 2023 3 through 2030, $216,000,000.’’; 4 (5) in subparagraph (D)— 5 (A) in the matter preceding clause (i), by 6 striking ‘‘$30,000,000’’ and inserting 7 ‘‘$250,000,000’’; and 8 (B) by striking clause (iv) and inserting 9 the following: 10 ‘‘(iv) For each of fiscal years 2021, 11 2022, and 2023, $50,000,000. 12 ‘‘(v) For each of fiscal years 2024 13 through 2030, $10,000,000.’’; and 14 (6) by adding at the end the following: 15 ‘‘(E) To support research related to com- 16 bating antimicrobial resistance and antibiotic 17 resistant bacteria, not to exceed a total of 18 $1,635,000,000, as follows: 19 ‘‘(i) For fiscal year 2021, 20 $100,000,000. 21 ‘‘(ii) For each of fiscal years 2022 22 through 2024, $150,000,000. 23 ‘‘(iii) For each of fiscal years 2025 24 through 2027, $175,000,000. 25 VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS 6 •HR 4667 IH ‘‘(iv) For each of fiscal years 2028 1 and 2029, $180,000,000. 2 ‘‘(v) For fiscal year 2030, 3 $200,000,000. 4 ‘‘(F) To support research and research ac- 5 tivities related to rare diseases or conditions, 6 not to exceed a total of $758,000,000, as fol- 7 lows: 8 ‘‘(i) For fiscal year 2021, 9 $50,000,000. 10 ‘‘(ii) For fiscal year 2022, 11 $55,000,000. 12 ‘‘(iii) For fiscal year 2023, 13 $60,000,000. 14 ‘‘(iv) For fiscal year 2024, 15 $65,000,000. 16 ‘‘(v) For fiscal year 2025, 17 $70,000,000. 18 ‘‘(vi) For fiscal year 2026, 19 $75,000,000. 20 ‘‘(vii) For fiscal year 2027, 21 $80,000,000. 22 ‘‘(viii) For fiscal year 2028, 23 $90,000,000. 24 VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS 7 •HR 4667 IH ‘‘(ix) For fiscal year 2029, 1 $100,000,000. 2 ‘‘(x) For fiscal year 2030, 3 $113,000,000.’’. 4 (e) WORKPLAN.—Section 1001(c)(1)(A) of the 21st 5 Century Cures Act (Public Law 114–255) is amended by 6 striking ‘‘2026’’ and inserting ‘‘2030’’. 7 (f) RECOMMENDATIONS.—Section 1001(c)(1)(C)(i) 8 of the 21st Century Cures Act (Public Law 114–255) is 9 amended by striking ‘‘2026’’ and inserting ‘‘2030’’. 10 (g) ANNUAL REPORTS.—Section 1001(c)(2)(A) of 11 the 21st Century Cures Act (Public Law 114–255) is 12 amended by striking ‘‘2027’’ and inserting ‘‘2030’’. 13 (h) SUNSET.—Section 1001(e) of the 21st Century 14 Cures Act (Public Law 114–255) is amended by striking 15 ‘‘September 30, 2026’’ and inserting ‘‘September 30, 16 2030’’. 17 Æ VerDate Sep 11 2014 03:00 Oct 12, 2019 Jkt 099200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6301 E:\BILLS\H4667.IH H4667 kjohnson on DSK79L0C42 with BILLS